| Date Filed | Type | Description |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/05/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 01/04/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 01/04/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 01/04/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 12/15/2010 |
8-K
| Quarterly results |
| 12/14/2010 |
BW
| Osteologix Announces Plans to Deregister Company Common Stock and Initiate Corporate Consolidation |
| 11/15/2010 |
10-Q
| Quarterly Report for the period ended September 30, 2010 |
| 10/18/2010 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 10/08/2010 |
8-K
| Form 8-K - Current report |
| 08/16/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/02/2010 |
8-K
| Form 8-K - Current report |
| 06/15/2010 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/14/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
| 06/11/2010 |
SC 13D/A
| Nordic Biotech K/S reports a 65.9% stake in Osteologix, Inc. |
| 06/11/2010 |
8-K
| Form 8-K - Current report |
| 05/17/2010 |
10-Q
| Quarterly Report for the period ended March 31, 2010 |
| 04/30/2010 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/30/2010 |
10-K/A
| Annual Report for the period ended December 31, 2009 [amend] |
| 03/31/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 02/16/2010 |
SC 13G/A
| BURLINGAME ASSET MANAGEMENT, LLC reports a 7.4% stake in Osteologix, Inc. |
| 02/04/2010 |
8-K/A
| Form 8-K - Current report [amend] |
| 02/03/2010 |
DEF 14C
| Form DEF 14C - Other definitive information statements |
| 01/28/2010 |
D
| Form D - Notice of Exempt Offering of Securities |
| 01/26/2010 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/08/2010 |
8-K
| Unregistered Sales of Equity Securities |
| 01/05/2010 |
SC 13D/A
| Nordic Biotech K/S reports a 64.3% stake in Osteologix, Inc. |
| 01/04/2010 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 11/16/2009 |
10-Q
| Quarterly Report for the period ended September 30, 2009 |
| 08/14/2009 |
10-Q
| Quarterly Report for the period ended June 30, 2009 |
| 08/05/2009 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/15/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
| 04/23/2009 |
8-K
| Form 8-K - Current report |
|